Patent: 10,039,836
✉ Email this page to a colleague
Summary for Patent: 10,039,836
| Title: | Polyamine-dihydroxybenzoic acid conjugate hydrogels as iron chelators |
| Abstract: | Compositions and methods for making a composition comprising a polymer and one or more chelators covalently coupled to polymer, wherein the one or more chelators has a benzene ring with more than one hydroxyl group at any position that is free, or a derivative of the chelator, or a salt of the chelator and methods of use. |
| Inventor(s): | Cory Berkland, Zahra Mohammadi |
| Assignee: | University of Kansas |
| Application Number: | US15/225,524 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,039,836
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Bristol-myers Squibb Company | YERVOY | ipilimumab | Injection | 125377 | 25-Mar-11 | ⤷ Start Trial | 2036-08-01 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,039,836
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2542248 | ⤷ Start Trial |
| Japan | 2013525268 | ⤷ Start Trial |
| United States of America | 2013056211 | ⤷ Start Trial |
| United States of America | 2017028072 | ⤷ Start Trial |
| United States of America | 2017028073 | ⤷ Start Trial |
| United States of America | 2018289819 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
